6VO0 image
Entry Detail
PDB ID:
6VO0
EMDB ID:
Keywords:
Title:
BG505 SOSIP.v5.2 in complex with rabbit Fab 43A2
Biological Source:
PDB Version:
Deposition Date:
2020-01-29
Release Date:
2020-07-01
Method Details:
Experimental Method:
Resolution:
3.52 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Envelope glycoprotein gp120
Chain IDs:C (auth: A), G (auth: C), K (auth: D)
Chain Length:475
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:Envelope glycoprotein gp41
Chain IDs:D (auth: B), H (auth: E), L (auth: F)
Chain Length:153
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:43A2 heavy chain
Chain IDs:B (auth: H), F (auth: G), J (auth: I)
Chain Length:120
Number of Molecules:3
Biological Source:Oryctolagus cuniculus
Polymer Type:polypeptide(L)
Description:43A2 light chain
Chain IDs:A (auth: L), E (auth: J), I (auth: K)
Chain Length:113
Number of Molecules:3
Biological Source:Oryctolagus cuniculus
Ligand Molecules
Primary Citation
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite.
Sci Adv 6 eaba0512 eaba0512 (2020)
PMID: 32548265 DOI: 10.1126/sciadv.aba0512

Abstact

To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers have revealed the 241/289 glycan hole as the dominant neutralizing antibody epitope. Here, we isolated monoclonal antibodies from a rabbit that did not exhibit glycan hole-dependent autologous serum neutralization. The antibodies did not compete with a previously isolated glycan hole-specific antibody but did compete with N332 glycan supersite broadly neutralizing antibodies. A 3.5-Å cryoEM structure of one of the antibodies in complex with the BG505 SOSIP.v5.2 trimer demonstrated that while the epitope recognized overlapped the N332 glycan supersite by contacting the GDIR motif at the base of V3, primary contacts were located in the variable V1 loop. These data suggest that strain-specific responses to V1 may interfere with broadly neutralizing responses to the N332 glycan supersite and vaccine immunogens may require engineering to minimize these off-target responses or steer them toward a more desirable pathway.

Legend

Protein

Chemical

Disease

Primary Citation of related structures